Scientists involved in cancer research, cancer medicine, or cancer-related biomedical science can nominate a colleague or professional associate for the 9th Pezcoller Foundation-AACR International Award for Cancer Research. The award was established in 1997 to annually recognize a scientist:

-- Who has made a major scientific discovery in basic cancer research or who has made significant contributions to translational cancer research;

-- Who continues to be active in cancer research and has a record of recent, noteworthy publications; and

-- Whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.

While intended to honor an individual, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter.

The Award consists of ?75,000 and a commemorative plaque.

The nomination process and other details about the award are located on the AACR Web site at aacr. The deadline for nominations is Friday, September 16, 2005.

The winner will give an award lecture during the 97th AACR Annual Meeting in Washington, DC, April 1-5, 2006, and will officially receive the award of ?75,000 at a May 2006 ceremony in Trento, Italy, where the Pezcoller Foundation is located.

Recent recipients of the Pezcoller Foundation-AACR International Award for Cancer Research are:

2005: Lewis C. Cantley, Ph.D.
Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass.

2004: Stanley J. Korsmeyer, M.D.
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass.
Howard Hughes Medical Institute

2003: Mario R. Capecchi, Ph.D.
Eccles Institute of Human Genetics, University of Utah, Salt Lake City

2002: Carl-Henrik Heldin, Ph.D.
Uppsala University, Uppsala, Sweden

Founded in 1907, the American Association for Cancer Research is a professional society of more than 24,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meetings attract nearly 16,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.

Elizabeth J. Tait
215/440-9300, ext. 144
taitaacr
aacr